Despite these promising findings, the TME in sarcomas remains highly immunosuppressive, characterized by elevated levels of regulatory T cells, macrophages with an M2-like phenotype, and the expression of immune checkpoint molecules such as PD-1 and PD-L1 [22,23]. Here, CD274 is linked to sarcoma.